Skip to main content

Advertisement

Open Peer Review Reports for: Active post-marketing surveillance of the intralesional administration of human recombinant epidermal growth factor in diabetic foot ulcers

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
8 Apr 2013 Submitted Original manuscript
1 Jun 2013 Reviewed Reviewer Report - Luigi Uccioli
27 Jun 2013 Reviewed Reviewer Report - Carlo Maria Ferdinando Caravaggi
28 Jun 2013 Author responded Author comments - Isis B. Yera-Alos
Resubmission - Version 2
28 Jun 2013 Submitted Manuscript version 2
23 Jul 2013 Reviewed Reviewer Report - Luigi Uccioli
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
30 Jul 2013 Editorially accepted
3 Sep 2013 Article published 10.1186/2050-6511-14-44

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement